A superiority of viral load over CD4 cell count when predicting mortality in HIV patients on therapy
Open Access
- 15 February 2019
- journal article
- research article
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 19 (1) , 1-10
Abstract
CD4 cell count has been identified to be an essential component in monitoring HIV treatment outcome. However, CD4 cell count monitoring sometimes fails to predict virological failure resulting in unnecessary switch of treatment lines which causes drug resistance and limitations of treatment options. This study assesses the use of both viral load (HIV RNA) and CD4 cell count in the monitoring of HIV/AIDS progression. Time-homogeneous Markov models were fitted, one on CD4 cell count monitoring and the other on HIV RNA monitoring. Effects of covariates; gender, age, CD4 baseline, HIV RNA baseline and adherence to treatment were assessed for each of the fitted models. Assessment of the fitted models was done using prevalence plots and the likelihood ratio tests. The analysis was done using the “msm” package in R. Results from the analysis show that viral load monitoring predicts deaths of HIV/AIDS patients better than CD4 cell count monitoring. Assessment of the fitted models shows that viral load monitoring is a better predictor of HIV/AIDS progression than CD4 cell count. From this study one can conclude that although patients take more time to achieve a normal CD4 cell count and less time to achieve an undetectable viral load, once the CD4 cell count is normal, mortality risks are reduced. Therefore, both viral load monitoring and CD4 count monitoring can be used to provide useful information which can be used to improve life expectance of patients living with HIV. However, viral load monitoring is a better predictor of HIV/AIDS progression than CD4 cell count and hence viral load is deemed superior.Keywords
This publication has 13 references indexed in Scilit:
- The evolving role of CD4 cell counts in HIV careCurrent Opinion in HIV and AIDS, 2017
- Viral load versus CD4+ monitoring and 5-year outcomes of antiretroviral therapy in HIV-positive children in Southern AfricaAIDS, 2014
- HIV infection: epidemiology, pathogenesis, treatment, and preventionThe Lancet, 2014
- Multi-state models for defining degrees of chronicity related to HIV-infected patient therapy adherenceCadernos de Saude Publica, 2013
- The interplay between CD4 cell count, viral load suppression and duration of antiretroviral therapy on mortality in a resource‐limited settingTropical Medicine & International Health, 2013
- Comparison of CD4 Cell Count, Viral Load, and Other Markers for the Prediction of Mortality among HIV‐1–Infected Kenyan Pregnant WomenThe Journal of Infectious Diseases, 2009
- Hepatotoxicity in an African antiretroviral therapy cohort: the effect of tuberculosis and hepatitis BAIDS, 2007
- Association of Virus Load, CD4 Cell Count, and Treatment with Clinical Progression in Human Immunodeficiency Virus–Infected Patients with Very Low CD4 Cell CountsThe Journal of Infectious Diseases, 2002
- HIV Viral Load Response to Antiretroviral Therapy According to the Baseline CD4 Cell Count and Viral LoadJAMA, 2001
- Effect of Antiretroviral Therapy on Viral Load, CD4 Cell Count, and Progression to Acquired Immunodeficiency Syndrome in a Community Human Immunodeficiency Virus–Infected CohortArchives of internal medicine (1960), 2000